Search Results 731-740 of 16339 for monoclonal antibody
... Antibody (ANCA) at 6 months. The study is a double ... - History of intolerance to rituximab or other chimeric monoclonal antibodies (e.g., infliximab).
... monoclonal antibody or kinase inhibitor. Participation in clinical trials ... Use of any neutralizing monoclonal antibodies such as bamlanivimab (LY ...
Known hypersensitivity to multiple drugs, monoclonal antibodies or other therapeutic proteins; A history or presence of other medical illness that indicates ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...
A Study of the Safety and Effectiveness of Eculizumab to Prevent Antibody-Mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation.
Monoclonal antibodies, such as durvalumab and tremelimumab, may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high ...
... monoclonal antibody and at least 1 steroid. Participant had at least a minimal response (MR) to the anti-CD38 antibody containing regimen and had last dose ...
The team also reported that an antibody used in their research blocked the internal function of PD-L1, making the cells more sensitive to treatment. PD-L1 ...
The objectives of this study are to determine the prevalence of spike (S) protein antibodies ... antibody development and determine how age and gender may affect ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.